+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Depyrogenated Sterile Empty Vials Market - Global Forecast 2026-2032- Product Image
Depyrogenated Sterile Empty Vials Market - Global Forecast 2026-2032- Product Image
New

Depyrogenated Sterile Empty Vials Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 189 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5977973
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global depyrogenated sterile empty vials market is becoming critical for senior pharmaceutical and healthcare leaders seeking robust solutions for product sterility, regulatory compliance, and reliable supply chains.

Market Snapshot: Depyrogenated Sterile Empty Vials Market

The Depyrogenated Sterile Empty Vials Market grew from USD 3.68 billion in 2025 to USD 3.90 billion in 2026. It is expected to continue growing at a CAGR of 6.50%, reaching USD 5.72 billion by 2032. Market expansion is fueled by accelerating biopharma innovation, heightened regulatory expectations, and increased demand for quality-driven primary containers among leading manufacturers and healthcare providers.

Scope & Segmentation

  • Container Types: Glass vials (clear and amber), high-grade polymer vials (polyethylene, polypropylene)
  • Material Types: Inert glass for enhanced barrier protection, plastics for breakage resistance and weight reduction
  • Container Sizes: Range from up to 2 mL to above 10 mL, supporting dosing accuracy for small-batch biologics and bulk pharmaceuticals
  • Applications: Vaccines, injectables, advanced therapeutics (cell/gene therapy), diagnostics (clinical chemistry, molecular assays)
  • End User Segments: Biotechnology firms, pharmaceutical manufacturers (innovative and generic), research institutes, diagnostic and clinical laboratories, hospitals (public and private)
  • Sterilization Technologies: Autoclave, gamma irradiation, ethylene oxide, validated closed-system processes
  • Regions: Americas, Europe-Middle East-Africa, Asia-Pacific

Key Takeaways for Senior Decision-Makers

  • Decision criteria for depyrogenated sterile empty vials are increasingly shaped by regulatory demands, manufacturing complexity, and evolving therapeutic pipelines.
  • Material compatibility and sterilization method selection are vital for protecting product potency, ensuring sterility, and supporting downstream fill-finish operations.
  • Regulatory scrutiny is driving manufacturers and suppliers to invest in process validation, traceability, and digital quality management systems for improved compliance.
  • Regional dynamics influence supplier selection and logistics strategies, with the Americas emphasizing quick market access, Europe-Middle East-Africa prioritizing regulatory harmonization, and Asia-Pacific offering significant production scale and cost efficiencies.
  • Sustainability is a growing factor in procurement, with buyers prioritizing suppliers who demonstrate lower carbon sterilization methods and recyclable packaging materials.

Tariff Impact on Sourcing and Qualification

Recent tariff adjustments in the United States are changing the structure of primary packaging procurement. Manufacturers are reassessing landed costs, considering nearshoring, and revising qualification pathways to ensure supply continuity and manage risk. These trade shifts intersect with regulatory workflows, extending qualification timelines and requiring additional compliance and audit documentation for alternative regional suppliers.

Methodology & Data Sources

This report draws on structured interviews with industry experts, technical managers, and procurement leaders, as well as in-depth reviews of regulatory guidance and sterilization standards. Data analysis integrates cross-sectional comparisons, regional scenario planning, and validation of findings through expert consensus and regulatory documentation.

Why This Report Matters

  • Supports procurement and technical teams in aligning material, sterilization, and supplier choices with compliance and quality goals.
  • Enables senior decision-makers to navigate tariff impacts, manage supply risks, and develop resilient sourcing strategies for critical primary containers.
  • Provides clear segmentation and technology insights to inform investment and product development choices.

Conclusion

Depyrogenated sterile empty vials are strategic assets central to product safety and operational resilience. Investment in supplier validation, regional sourcing agility, and process transparency positions organizations to optimize outcomes across manufacturing and patient care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Depyrogenated Sterile Empty Vials Market, by Product Type
8.1. Glass Vials
8.1.1. Amber
8.1.2. Clear
8.2. Plastic Vials
8.2.1. Polyethylene
8.2.2. Polypropylene
9. Depyrogenated Sterile Empty Vials Market, by Capacity
9.1. Above 10 Ml
9.2. Above 2 To 5 Ml
9.3. Above 5 To 10 Ml
9.4. Up To 2 Ml
10. Depyrogenated Sterile Empty Vials Market, by Sterilization Method
10.1. Autoclave
10.2. Ethylene Oxide
10.3. Gamma Radiation
11. Depyrogenated Sterile Empty Vials Market, by Application
11.1. Biotechnology
11.1.1. Cell Therapy
11.1.2. Gene Therapy
11.2. Diagnostics
11.2.1. Clinical Chemistry
11.2.2. Immunodiagnostics
11.2.3. Molecular Diagnostics
11.3. Injectables
11.4. Vaccines
11.4.1. COVID-19
11.4.2. Influenza
12. Depyrogenated Sterile Empty Vials Market, by End User
12.1. Biotechnology Firms
12.2. Diagnostic Laboratories
12.2.1. Hospital Based Laboratories
12.2.2. Independent Laboratories
12.3. Hospitals
12.3.1. Private Hospitals
12.3.2. Public Hospitals
12.4. Pharmaceutical Companies
12.4.1. Generic Manufacturers
12.4.2. Innovator Companies
12.5. Research Institutes
12.5.1. Academic Institutions
12.5.2. Government Research Centers
13. Depyrogenated Sterile Empty Vials Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Depyrogenated Sterile Empty Vials Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Depyrogenated Sterile Empty Vials Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Depyrogenated Sterile Empty Vials Market
17. China Depyrogenated Sterile Empty Vials Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Agilent Technologies, Inc.
18.6. Amposan S.A.
18.7. APG Pharma
18.8. Bormioli Pharma
18.9. Consol Glass
18.10. Corning Incorporated
18.11. DWK Life Sciences
18.12. Gerresheimer AG
18.13. Hindusthan National Glass & Industries Ltd.
18.14. Kapoor Glass Private Limited
18.15. Merck KGaA
18.16. Nipro Corporation
18.17. Ompi part of Stevanato Group
18.18. Pacific Vial Manufacturing Inc.
18.19. Radpharm Scientific
18.20. SCHOTT AG
18.21. SGD Pharma
18.22. Shandong Pharmaceutical Glass Co. Ltd.
18.23. SiO2 Materials Science
18.24. Stevanato Group
18.25. Stoelzle Glass Group
18.26. Thermo Fisher Scientific Inc.
18.27. Triveni Polymers Pvt. Ltd.
18.28. West Pharmaceutical Services Inc
List of Figures
FIGURE 1. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY AMBER, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY AMBER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY AMBER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CLEAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CLEAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CLEAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 10 ML, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 10 ML, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 10 ML, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 2 TO 5 ML, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 2 TO 5 ML, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 2 TO 5 ML, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 5 TO 10 ML, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 5 TO 10 ML, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ABOVE 5 TO 10 ML, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY UP TO 2 ML, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY UP TO 2 ML, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY UP TO 2 ML, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY AUTOCLAVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY AUTOCLAVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY AUTOCLAVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ETHYLENE OXIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ETHYLENE OXIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ETHYLENE OXIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GAMMA RADIATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GAMMA RADIATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GAMMA RADIATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CELL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CELL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GENE THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GENE THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY IMMUNODIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY IMMUNODIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INJECTABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INJECTABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COVID-19, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COVID-19, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COVID-19, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INFLUENZA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INFLUENZA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITAL BASED LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GENERIC MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GENERIC MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GENERIC MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INNOVATOR COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INNOVATOR COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY INNOVATOR COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GOVERNMENT RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
TABLE 133. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
TABLE 134. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 135. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 136. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 137. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 138. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 140. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 141. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 142. AMERICAS DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2032 (USD MILLION)
TABLE 146. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2032 (USD MILLION)
TABLE 147. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
TABLE 148. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
TABLE 149. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 150. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 151. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 152. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 153. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 155. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 156. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 157. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 160. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2032 (USD MILLION)
TABLE 161. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2032 (USD MILLION)
TABLE 162. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
TABLE 163. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
TABLE 164. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 166. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 167. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 168. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 170. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 171. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 172. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2032 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2032 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 188. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 190. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2032 (USD MILLION)
TABLE 191. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2032 (USD MILLION)
TABLE 192. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
TABLE 193. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
TABLE 194. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 195. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 196. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 197. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 198. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 200. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 201. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 202. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 203. MIDDLE EAST DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. MIDDLE EAST DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 205. MIDDLE EAST DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2032 (USD MILLION)
TABLE 206. MIDDLE EAST DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2032 (USD MILLION)
TABLE 207. MIDDLE EAST DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
TABLE 208. MIDDLE EAST DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
TABLE 209. MIDDLE EAST DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 210. MIDDLE EAST DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 211. MIDDLE EAST DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 212. MIDDLE EAST DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 213. MIDDLE EAST DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 214. MIDDLE EAST DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 215. MIDDLE EAST DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 216. MIDDLE EAST DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 217. MIDDLE EAST DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 218. AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 219. AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 220. AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2032 (USD MILLION)
TABLE 221. AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2032 (USD MILLION)
TABLE 222. AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
TABLE 223. AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
TABLE 224. AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 226. AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 227. AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 228. AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 230. AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 231. AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 232. AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 233. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 234. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 235. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2032 (USD MILLION)
TABLE 236. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2032 (USD MILLION)
TABLE 237. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
TABLE 238. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
TABLE 239. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 240. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 241. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 242. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 243. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 244. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 245. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 246. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 247. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 248. GLOBAL DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 249. ASEAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. ASEAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 251. ASEAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2032 (USD MILLION)
TABLE 252. ASEAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2032 (USD MILLION)
TABLE 253. ASEAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
TABLE 254. ASEAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
TABLE 255. ASEAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 256. ASEAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 257. ASEAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 258. ASEAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 259. ASEAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 260. ASEAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 261. ASEAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 262. ASEAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 263. ASEAN DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 264. GCC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. GCC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 266. GCC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2032 (USD MILLION)
TABLE 267. GCC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2032 (USD MILLION)
TABLE 268. GCC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
TABLE 269. GCC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
TABLE 270. GCC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 271. GCC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 272. GCC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
TABLE 273. GCC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 274. GCC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 275. GCC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
TABLE 276. GCC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 277. GCC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 278. GCC DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY GLASS VIALS, 2018-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY PLASTIC VIALS, 2018-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY CAPACITY, 2018-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY STERILIZATION METHOD, 2018-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION DEPYROGENATED STERILE EMPTY VIALS MARKET SIZE, BY DIAGNOSTICS, 2018-2032

Companies Mentioned

The key companies profiled in this Depyrogenated Sterile Empty Vials market report include:
  • Agilent Technologies, Inc.
  • Amposan S.A.
  • APG Pharma
  • Bormioli Pharma
  • Consol Glass
  • Corning Incorporated
  • DWK Life Sciences
  • Gerresheimer AG
  • Hindusthan National Glass & Industries Ltd.
  • Kapoor Glass Private Limited
  • Merck KGaA
  • Nipro Corporation
  • Ompi part of Stevanato Group
  • Pacific Vial Manufacturing Inc.
  • Radpharm Scientific
  • SCHOTT AG
  • SGD Pharma
  • Shandong Pharmaceutical Glass Co. Ltd.
  • SiO2 Materials Science
  • Stevanato Group
  • Stoelzle Glass Group
  • Thermo Fisher Scientific Inc.
  • Triveni Polymers Pvt. Ltd.
  • West Pharmaceutical Services Inc

Table Information

Report AttributeDetails
No. of Pages189
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.9 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.72 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Depyrogenated Sterile Empty Vials Market Report 2025 - Product Image

Depyrogenated Sterile Empty Vials Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Sterile Vials - Global Strategic Business Report - Product Image

Sterile Vials - Global Strategic Business Report

  • Report
  • 481 Pages
  • Global
From
Cryogenic Vials Market - Global Forecast 2026-2032 - Product Image

Cryogenic Vials Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Cyclic Olefin Polymer Vials Market - Global Forecast 2025-2030 - Product Image

Cyclic Olefin Polymer Vials Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Container Closure Integrity Testing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Container Tested (Vials, Syringes, and Cartridges), Type of Container Material Tested (Glass and Plastic) and Key Geographical Regions - Product Image

Container Closure Integrity Testing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Container Tested (Vials, Syringes, and Cartridges), Type of Container Material Tested (Glass and Plastic) and Key Geographical Regions

  • Report
  • 212 Pages
  • Global
From

About the Depyrogenated Sterile Empty Vials Market

The Depyrogenated Sterile Empty Vials market is a subset of the Drug Discovery industry. It is a specialized market that focuses on the production of sterile, empty vials that have been depyrogenated. This process involves the removal of pyrogens, which are substances that can cause fever in humans. Depyrogenated vials are used in the production of injectable drugs, and are essential for ensuring the safety of the drug. The market is highly regulated, and manufacturers must adhere to strict quality standards. The Depyrogenated Sterile Empty Vials market is highly competitive, with many companies offering a range of products. Some of the major players in the market include West Pharmaceutical Services, Inc., Nipro Corporation, Schott AG, and Corning Incorporated. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.